Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GORE VIABAHN® Endoprosthesis Versus Percutaneous Transluminal Angioplasty (PTA) to Revise Arteriovenous Grafts at the Venous Anastomosis in Hemodialysis Patients

NCT00737672 is registered in ClinicalTrials.gov with W.L.Gore & Associates as lead sponsor.

NCT NCT00737672
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00737672 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GORE VIABAHN® Endoprosthesis Versus Percutaneous Transluminal Angioplasty (PTA) to Revise Arteriovenous Grafts at the Venous Anastomosis in Hemodialysis Patients
Lead sponsor
W.L.Gore & Associates
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2008
Completion date
June 30, 2013
Enrollment
293 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

hemodialysis, renal failure